sTCR bispec

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamesTCR bispec

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy

Mechanisms of ActionT lymphocytes modulators

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmatics NV

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesImmatics NV

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A